Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Immunisation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06639386
What this trial is testing

Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups

Who this might be right for
Vaccine HesitancyVaccine Refusal
Boston Medical Center 68
Not applicableStudy completedNCT01107535
What this trial is testing

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infection
Abbott 82
Not applicableActive Not RecruitingNCT07249320
What this trial is testing

Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 1
Post-approval studies (Phase 4)Not Yet RecruitingNCT07296120
What this trial is testing

RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients

Who this might be right for
CAR-T Cell TherapyRSV ImmunizationBone Marrow Transplant - Autologous or Allogeneic
The Cooper Health System 30
Testing effectiveness (Phase 2)Study completedNCT04752644
What this trial is testing

Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults

Who this might be right for
RSV Infection
Bavarian Nordic 73
Large-scale testing (Phase 3)Study completedNCT05705440
What this trial is testing

A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 3,855
Testing effectiveness (Phase 2)Looking for participantsNCT06597916
What this trial is testing

RSV Vaccination in Immunocompromised Patients.

Who this might be right for
RSV Infection
Medical University of Vienna 200
Not applicableLooking for participantsNCT07615192
What this trial is testing

RSV Immunisation Status in Queensland (Australia)

Who this might be right for
RSV Immunization
Sanofi 1,200
Testing effectiveness (Phase 2)Study completedNCT03334695
What this trial is testing

An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 64
Not applicableStudy completedNCT06185647
What this trial is testing

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)Immunization; Infection
Hôpital Armand Trousseau 4,924
Post-approval studies (Phase 4)Looking for participantsNCT07097012
What this trial is testing

Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy

Who this might be right for
RSVTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationPregnancy+1 more
Canadian Immunization Research Network 60
Large-scale testing (Phase 3)Ended earlyNCT06252285
What this trial is testing

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunisation
Sanofi Pasteur, a Sanofi Company 6,300
Large-scale testing (Phase 3)Study completedNCT02624947
What this trial is testing

Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Who this might be right for
Respiratory Syncytial Virus Infections
Novavax 4,636
Not applicableActive Not RecruitingNCT07122661
What this trial is testing

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Syncytial VirusLower Respiratory Tract Disease+2 more
Pfizer 1
Large-scale testing (Phase 3)Study completedNCT02968173
What this trial is testing

Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus

Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 50
Not applicableLooking for participantsNCT07171164
What this trial is testing

Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults

Who this might be right for
Older Adults Without Any Specific Clinical ConditionSocial NetworksRSV Immunization+1 more
University of California, San Francisco 750
Testing effectiveness (Phase 2)WithdrawnNCT03191383
What this trial is testing

Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Post-approval studies (Phase 4)Study completedNCT00001903
What this trial is testing

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Study completedNCT01905215
What this trial is testing

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines

Who this might be right for
Infections, Respiratory Syncytial Virus
GlaxoSmithKline 128
Early research (Phase 1)Study completedNCT07071558
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi 240
Next Page